Tag Archives: Binx Health

March 2024—Binx Health announced it has entered into a national distribution agreement with Cardinal Health to expand access to care with its CLIA-waived, FDA-cleared Binx IO. The molecular point-of-care platform is used to detect chlamydia and gonorrhea in male and female patient samples and provides results in about 30 minutes.

Feb. 21 2024—Binx Health announced a national distribution agreement with Cardinal Health to expand access to care with its CLIA-waived, FDA-cleared Binx IO.